清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Ressuscitação Cardiopulmonar Extracorpórea para Parada Cardiorrespiratória Intra-Hospitalar: Experiência de um Centro na América Latina

医学 体外膜肺氧合 妇科 体外循环 外科 内科学 死亡率 无症状的 回顾性队列研究 呼吸衰竭
作者
Lucrecia María Burgos,Leonardo A. Seoane,Ana Spaccavento,Juan Furmento,Juan P. Costabel,Rocío Consuelo Baro Vila,María Antonella De Bortoli,Daniel O. Navia,Fernando Piccinini,Mariano Vrancic,Mirta Díez
出处
期刊:Arquivos Brasileiros De Cardiologia [Sociedade Brasileira de Cardiologia (SBC)]
卷期号:123 (3): e20240820-e20240820 被引量:1
标识
DOI:10.36660/abc.20240820
摘要

BACKGROUND: Extracorporeal cardiopulmonary resuscitation (ECPR) is the use of extracorporeal membrane oxygenation (ECMO) in patients in whom conventional cardiopulmonary resuscitation measures have failed to achieve a sustained return of spontaneous circulation after cardiorespiratory arrest. Limited information is available in centers in Latin America. OBJECTIVE: To evaluate in-hospital and long-term clinical outcomes of adult patients treated with ECPR after in-hospital cardiac arrest (IHCA) in a high-complexity center in Argentina. METHODS: A single-center cohort study was performed. Consecutive adult patients who underwent ECPR between 2014 and 2023 were retrospectively analyzed. Witnessed IHCA cases of probable cardiac origin were included. RESULTS: Fifteen patients were included in the analysis, representing 16% of the venoarterial ECMO cases implanted at the center during this period. The median age was 46 years (interquartile range [IQR]: 34 to 57); 33% were female. Cannulation was peripheral in 93.3%, and 66% of ECMO runs were placed with an initial bridging strategy to recovery. The median duration of circulatory support was 5 days (IQR: 2 to 9). Venoarterial ECMO was successfully removed in 60% of patients, and in-hospital survival was 46%. Median follow-up after discharge was 12 months (IQR: 3 to 34), with 100% long-term survival. CONCLUSION: Venoarterial ECMO as a treatment for IHCA in our center demonstrated acceptable survival to hospital discharge and long-term survival. Venoarterial ECMO may be an effective treatment in highly selected patients when conventional therapies fail and may be useful and applicable in a low- and middle-income country with limited access to other circulatory assist devices.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
迷你的蜜粉完成签到,获得积分10
3秒前
大个的应助被Gilgardea采纳,获得10
14秒前
汉堡包的应助被辅助但上分采纳,获得10
24秒前
忧郁凝阳完成签到,获得积分10
32秒前
整齐成协完成签到,获得积分10
37秒前
45秒前
冥土追魂完成签到,获得积分10
46秒前
冥土追魂发布了新的文献求助10
49秒前
丘比特的应助被武雨寒采纳,获得10
1分钟前
懵懂的小之完成签到,获得积分10
1分钟前
专注的怜珊完成签到,获得积分10
1分钟前
完美世界的应助被武雨寒采纳,获得10
1分钟前
科研通AI6.4的应助被cat采纳,获得10
1分钟前
1分钟前
羞涩的傲菡完成签到,获得积分10
1分钟前
武雨寒发布了新的文献求助10
1分钟前
兴奋乞完成签到,获得积分10
1分钟前
零度空间完成签到,获得积分10
1分钟前
痴情的不惜完成签到,获得积分10
1分钟前
1分钟前
整齐念薇完成签到,获得积分10
1分钟前
武雨寒发布了新的文献求助10
1分钟前
2分钟前
诸葛平卉完成签到 ,获得积分10
2分钟前
星辰大海的应助被psm采纳,获得10
2分钟前
2分钟前
飞天大南瓜完成签到,获得积分10
2分钟前
Gilgardea发布了新的文献求助10
2分钟前
车车完成签到 ,获得积分10
2分钟前
精明开山完成签到,获得积分10
2分钟前
2分钟前
鲤鱼遥完成签到,获得积分10
2分钟前
cat发布了新的文献求助10
2分钟前
AG完成签到,获得积分10
2分钟前
田田完成签到 ,获得积分10
2分钟前
2分钟前
等待凡英完成签到,获得积分10
2分钟前
陈荆洲完成签到,获得积分10
2分钟前
高高的玉兰完成签到,获得积分10
2分钟前
2分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Hidden Empire of Finance: How Wall Street Profits from Our Cities and Fuels Global Inequality 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8166413
求助须知:如何正确求助?哪些是违规求助? 9559494
关于积分的说明 21750478
捐赠科研通 7757221
什么是DOI,文献DOI怎么找? 3429141
关于科研通互助平台的介绍 2553489
邀请新用户注册赠送积分活动 2473835